Related Experiment Videos
Reducing snacks when switching from conventional soluble to lispro insulin treatment: effects on glycaemic control
1Department of Medicine, University of Turku, Finland.
Abstract:
The lack of significant improvement in HbA1c during insulin lispro treatment in previous studies may have been due to inadequate dietary adjustments. We tested whether reduction of snacks and a compensatory increase in main meals results in improved metabolic control when switching to lispro treatment. One hundred and forty-one Type 1 diabetic patients, mean +/- SD age 36 +/- 9 years, diabetes duration 14 +/- 10 years, had two daily NPH injections throughout the study. After a baseline visit, the patients used conventional soluble insulin preprandially thrice daily for 12 weeks. Thereafter they were switched to lispro insulin and advised to transfer > or =50% of their snack carbohydrates to preceding main meals. Mean HbA1c at baseline was 8.05%. After the conventional period and the 12-week lispro period, HbA1c was 7.81 and 7.70% (p = 0.088), respectively. In those patients who diminished their snacks as advised (n = 67), HbA1c decreased from 7.91 to 7.66% (p = 0.014) during lispro, whereas no change was observed in patients not compliant with the dietary change. The number of hypoglycaemic episodes was lower during lispro period (blood glucose <2.5 mmol l(-1): 1.43 vs 2.19 episodes, p = 0.004; symptomatic nocturnal hypoglycaemia 1.16 vs 1.67 episodes, p<0.001). When switching from conventional soluble to lispro insulin, reduction of snack carbohydrates is safe and results in slightly improved HbA1c in patients who are fully compliant with the dietary change.